[ad_1] Amid an uptick in COVID-19 hospitalizations, vaccine makers say the updated shots they’ve developed…
MRNA
-
-
STOCK MARKET
Moderna’s stock jumps 5% premarket after narrower-than-expected loss and revenue beat
by userby user[ad_1] Moderna Inc.’s stock MRNA, -3.26% rallied 5.5% in premarket trade Thursday, after the COVID…
-
STOCK MARKET
Novavax’s stock soars after positive COVID and flu trial data and news of plan to lay off 25% of workforce
by userby user[ad_1] Novavax Inc.’s stock soared Tuesday after the biotech company reported positive results from a…
-
STOCK MARKET
Moderna, Merck combo cancer-vaccine treatment shows ‘significant’ promise
by userby user[ad_1] A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising…
-
STOCK MARKET
Drug manufacturer Catalent’s stock tumbles 25% after profit warning and CFO departure
by userby user[ad_1] Catalent Inc.’s stock tumbled 25% Friday, putting it on track for its second biggest…
-
STOCK MARKET
Moderna is developing a Lyme disease vaccine in a first for the company
by userby user[ad_1] Moderna Inc. said Tuesday it’s working to develop its first bacterial vaccine to protect…
-
STOCK MARKET
How a nasal vaccine could reduce the risk of COVID infections — and new variants
by userby user[ad_1] For many, one of the defining moments of the COVID-19 pandemic was when they…
-
[ad_1] In the latest sign that the coronavirus pandemic is not yet over, the World…
-
STOCK MARKET
China slams Western media for criticism of zero-COVID, as U.S. cases continue to decline
by userby user[ad_1] China has accused “some Western media” of bias and political manipulation in covering China’s…
-
[ad_1] U.S. stock indexes opened higher on Wednesday, after more data suggested inflation may be…